American Journal of Ophthalmology
Volume 145, Issue 5 , Pages 862-874.e3, May 2008

Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results

  • Andrew N. Antoszyk

      Affiliations

    • Charlotte Eye, Ear, Nose and Throat Associates, Charlotte, North Carolina
    • Corresponding Author InformationInquiries to Andrew N. Antoszyk, Charlotte Eye, Ear, Nose and Throat Associates, 6035 Fairview Road, Charlotte, NC 28210
    • ,
  • Lisa Tuomi

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • Carol Y. Chung

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • Angele Singh

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • FOCUS Study Group

Accepted 22 December 2007. published online 13 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supplemental Material available at AJO.com.

PII: S0002-9394(08)00008-1

doi:10.1016/j.ajo.2007.12.029

American Journal of Ophthalmology
Volume 145, Issue 5 , Pages 862-874.e3, May 2008

Article Tools

* Image Usage & Resolution